Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Time-in-Range: A Key Determinant of Quality of Life

Time-in-Range: A Key Determinant of Quality of Life

Time-in-Range: A Key Determinant of Quality of Life

Næsten 60 % af patienter med svær astma havde mindst 2 forhøjede biomarkører

Rare Disease University - Universität für seltene Krankheiten (RDU)

Feno er en stærk markør for eksacerbationer

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.